Slide background
Slide background
Slide background
Slide background
Slide background

Currently recruiting patients with

Active Rheumatoid Arthritis

PURPOSE:

To demonstrate BMAC/PRxP cell therapy is safe & effective

For patients that have had inadequate treatment with an ANTI-TNF

Length of study: 1 year
Target Age: 18 years and older
Travel Stipend: yes
Benefits include free doctor visits,
one-on-one care with a study coordinator,
free medication
Enrollment deadline is March 22, 2014.